Biocept Inc logo

BIOC - Biocept Inc News Story

$4.36 -0.0  -0.7%

Last Trade - 16/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £42.3m
Enterprise Value £33.6m
Revenue £19.9m
Position in Universe 5515th / 6850

BRIEF-Biocept's Target Selector Liquid Biopsy Shows High Accuracy In Monitoring Metastatic Breast Cancer

Thu 10th December, 2020 1:40pm
Dec 10 (Reuters) - Biocept Inc  BIOC.O :
    * BIOCEPT INC - CO'S TARGET SELECTOR LIQUID BIOPSY
DEMONSTRATED
HIGH ACCURACY WHEN USED FOR MONITORING PROGRESSION OF METASTATIC
BREAST CANCER

Source text for Eikon:  ID:nPnbwd79a 
Further company coverage:  BIOC.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.